282 related articles for article (PubMed ID: 10812731)
1. Stopping poliovirus vaccination after eradication: issues and challenges.
Wood DJ; Sutter RW; Dowdle WR
Bull World Health Organ; 2000; 78(3):347-57. PubMed ID: 10812731
[TBL] [Abstract][Full Text] [Related]
2. Possible global strategies for stopping polio vaccination and how they could be harmonized.
Cochi SL; Sutter RW; Aylward RB
Dev Biol (Basel); 2001; 105():153-8; discussion 159. PubMed ID: 11763323
[TBL] [Abstract][Full Text] [Related]
3. Polio eradication: the OPV paradox.
Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
[TBL] [Abstract][Full Text] [Related]
4. Polio control after certification: major issues outstanding.
Fine PE; Oblapenko G; Sutter RW
Bull World Health Organ; 2004 Jan; 82(1):47-52. PubMed ID: 15106300
[TBL] [Abstract][Full Text] [Related]
5. The role of routine polio immunization in the post-certification era.
Sutter RW; Cáceres VM; Mas Lago P
Bull World Health Organ; 2004 Jan; 82(1):31-9. PubMed ID: 15106298
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of poliomyelitis--options and update.
Dutta A
Vaccine; 2008 Oct; 26(45):5767-73. PubMed ID: 18755232
[TBL] [Abstract][Full Text] [Related]
7. [End phase challenges of poliomyelitis eradication programme realization].
Jarzabek Z
Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
[TBL] [Abstract][Full Text] [Related]
8. Risk management in a polio-free world.
Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
[TBL] [Abstract][Full Text] [Related]
9. Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission.
Aylward RB; Cochi SL
Bull World Health Organ; 2004 Jan; 82(1):40-6. PubMed ID: 15106299
[TBL] [Abstract][Full Text] [Related]
10. The scientific basis for stopping polio immunisation--issues and challenges.
Wood DJ
Dev Biol (Basel); 2001; 105():69-72. PubMed ID: 11763339
[TBL] [Abstract][Full Text] [Related]
11. The risks of stopping vaccination: perspectives from the developing world.
Schoub BD
Bull World Health Organ; 2000; 78(3):360-1. PubMed ID: 10812734
[No Abstract] [Full Text] [Related]
12. Safe landing for global polio eradication: a perspective.
Arita I; Francis DP
Vaccine; 2011 Nov; 29(48):8827-34. PubMed ID: 21959326
[TBL] [Abstract][Full Text] [Related]
13. Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?
Khan MM
Vaccine; 2008 Apr; 26(16):2034-40. PubMed ID: 18339460
[TBL] [Abstract][Full Text] [Related]
14. World wide experience with inactivated poliovirus vaccine.
Bonnet MC; Dutta A
Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
[TBL] [Abstract][Full Text] [Related]
15. Strengths and weaknesses of current polio vaccines--a view from industry.
André FE
Dev Biol (Basel); 2001; 105():61-6. PubMed ID: 11763338
[TBL] [Abstract][Full Text] [Related]
16. [Global eradication of poliomyelitis. On the 80th anniversary of the founding of the National Institute of Health].
Slonim D
Epidemiol Mikrobiol Imunol; 2005 Aug; 54(3):99-108. PubMed ID: 16173520
[TBL] [Abstract][Full Text] [Related]
17. Progress toward global eradication of poliomyelitis, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(12):253-6. PubMed ID: 11939704
[TBL] [Abstract][Full Text] [Related]
18. A developing country perspective on vaccine-associated paralytic poliomyelitis.
John TJ
Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
[TBL] [Abstract][Full Text] [Related]
19. Cost analysis of post-polio certification immunization policies.
Sangrujee N; Cáceres VM; Cochi SL
Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295
[TBL] [Abstract][Full Text] [Related]
20. [The perspective of global eradication of poliomyelitis].
Knolle H; Egli A; Candrian U
Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
